European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol joint report on a new psychoactive substance: methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl) amino]piperidine-4-carboxylate (carfentanil). Luxembourg: Publications Office of the European Union.
| Preview | Title | Contact |
|---|---|---|
|
PDF (Carfentanil)
- Published Version
336kB |
In May 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil), through a joint assessment. The two organisations launched a data collection on this substance for the preparation of a Joint Report as stipulated by Article 5.1 of the Council Decision. The Joint Report was submitted to the Council, the Commission and the European Medicines Agency on 27 July 2017.
Table of contents
- Introduction
- Information collection process
- Information required by Article 5.2 of the Council Decision
- Information from the EMA (Article 5.3 of the Council Decision)
- Conclusion
- References
E Concepts in biomedical areas > Pharmacology and toxicology
J Health care, prevention, harm reduction and treatment > Risk and needs assessment > Risk assessment
L Social psychology and related concepts > Legal availability or accessibility
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > Europe
Repository Staff Only: item control page